Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
This study has been completed.
Study NCT00157339 Information provided by Eli Lilly and Company
First Received on September 7, 2005. Last Updated on July 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus
Asthma
Additional conditions recognized in this trial
Chronic Disease
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Bronchial Diseases
Disease Attributes
Endocrine System Diseases
Glucose Metabolism Disorders
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases, Obstructive
Metabolic Diseases
Pathologic Processes
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
Human Insulin Inhalation Powder
injected insulin
Additional drug interventions recognized in this trial
Insulin
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eli Lilly and Company
Alkermes
Back to top of Main Content
